171 related articles for article (PubMed ID: 26186128)
1. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.
Nelson JA; Fokar A; Hudgens MG; Compliment KJ; Hawkins JT; Tegha G; Kamwendo DD; Kayira D; Mofolo IA; Kourtis AP; Jamieson DJ; Van Der Horst CM; Fiscus SA
AIDS; 2015 Oct; 29(16):2131-8. PubMed ID: 26186128
[TBL] [Abstract][Full Text] [Related]
2. Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.
Fogel JM; Mwatha A; Richardson P; Brown ER; Chipato T; Alexandre M; Moodley D; Elbireer A; Mirochnick M; George K; Mofenson LM; Zwerski S; Coovadia HM; Eshleman SH
Pediatr Infect Dis J; 2013 Apr; 32(4):e164-9. PubMed ID: 23249916
[TBL] [Abstract][Full Text] [Related]
3. Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
Permar SR; Salazar MG; Gao F; Cai F; Learn GH; Kalilani L; Hahn BH; Shaw GM; Salazar-Gonzalez JF
Retrovirology; 2013 Aug; 10():88. PubMed ID: 23941304
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
5. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
6. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
Fogel J; Hoover DR; Sun J; Mofenson LM; Fowler MG; Taylor AW; Kumwenda N; Taha TE; Eshleman SH
AIDS; 2011 Apr; 25(7):911-7. PubMed ID: 21487249
[TBL] [Abstract][Full Text] [Related]
7. HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.
Dow DE; Schimana W; Nyombi BM; Mmbaga BT; Shayo AM; Bartlett JA; Massambu CG; Kifaro EG; Turner EL; DeMarco T; Cai F; Cunningham CK; Buchanan AM
AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1107-1113. PubMed ID: 28797181
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral interventions for preventing breast milk transmission of HIV.
White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
[TBL] [Abstract][Full Text] [Related]
9. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
Lidström J; Li Q; Hoover DR; Kafulafula G; Mofenson LM; Fowler MG; Thigpen MC; Kumwenda N; Taha TE; Eshleman SH
AIDS; 2010 Jan; 24(3):381-6. PubMed ID: 19996936
[TBL] [Abstract][Full Text] [Related]
10. Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.
MacLeod IJ; Rowley CF; Thior I; Wester C; Makhema J; Essex M; Lockman S
J Clin Virol; 2010 Jul; 48(3):162-7. PubMed ID: 20427228
[TBL] [Abstract][Full Text] [Related]
11. Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.
Moorthy A; Gupta A; Bhosale R; Tripathy S; Sastry J; Kulkarni S; Thakar M; Bharadwaj R; Kagal A; Bhore AV; Patil S; Kulkarni V; Venkataramani V; Balasubramaniam U; Suryavanshi N; Ziemniak C; Gupte N; Bollinger R; Persaud D
PLoS One; 2009; 4(1):e4096. PubMed ID: 19119321
[TBL] [Abstract][Full Text] [Related]
12. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
[TBL] [Abstract][Full Text] [Related]
13. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
14. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.
Fogel J; Li Q; Taha TE; Hoover DR; Kumwenda NI; Mofenson LM; Kumwenda JJ; Fowler MG; Thigpen MC; Eshleman SH
Clin Infect Dis; 2011 Apr; 52(8):1069-76. PubMed ID: 21460326
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.
Fowler MG; Coovadia H; Herron CM; Maldonado Y; Chipato T; Moodley D; Musoke P; Aizire J; Manji K; Stranix-Chibanda L; Fawzi W; Chetty V; Msweli L; Kisenge R; Brown E; Mwatha A; Eshleman SH; Richardson P; Allen M; George K; Andrew P; Zwerski S; Mofenson LM; Jackson JB;
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):366-74. PubMed ID: 24189151
[TBL] [Abstract][Full Text] [Related]
16. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).
Towler WI; Church JD; Eshleman JR; Fowler MG; Guay LA; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1209-13. PubMed ID: 18788912
[TBL] [Abstract][Full Text] [Related]
18. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
Church JD; Omer SB; Guay LA; Huang W; Lidstrom J; Musoke P; Mmiro F; Jackson JB; Eshleman SH
J Infect Dis; 2008 Oct; 198(7):1075-82. PubMed ID: 18684096
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
20. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
